CIK 0001832038
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851403134
- Phone
- +1 781-819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-18 | Hering David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +950,000 | 950,000 | ||
| 2022-12-14 | Hering David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2022-12-14 | Hering David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +900,000 | 900,000 | ||
| 2022-09-01 | Hering David Chief Executive Officer | Purchase | +8,000 | $4.52 | $36K | 8,000 |
| 2022-07-05 | Hering David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +2,000,000 | 2,000,000 | ||
| 2022-01-30 | Hering David Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +475,000 | 475,000 |
Page 1 of 1 · 6 trades